Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13732037 | 0.83 | L3MBTL1 (0.33) | MEN1KMT2AL3MBTL1TDP1ALDH1A1 | |
| SCHEMBL13052083 | 0.78 | OPRM1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2HTT | |
| SCHEMBL27431500 | 0.77 | HSD11B1 (0.34) | MEN1KMT2AL3MBTL1ALDH1A1SMN1; SMN2 | |
| SCHEMBL7229057 | 0.74 | CYP2B6 (0.31) | CYP2B6MAPT | |
| SCHEMBL7229061 | 0.74 | CYP2B6 (0.31) | CYP2B6MAPT | |
| SCHEMBL7221803 | 0.74 | CYP2B6 (0.31) | CYP2B6MAPT | |
| SCHEMBL7229066 | 0.74 | CYP2B6 (0.31) | CYP2B6MAPT | |
| SCHEMBL13052071 | 0.73 | HSD11B1 (0.37) | MEN1KMT2AALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL8827280 | 0.73 | ALDH1A1 (0.45) | MEN1KMT2AALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL26039065 | 0.72 | ALDH1A1 (0.39) | L3MBTL1ALDH1A1SMN1; SMN2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7838110-B2 | Aziridine-functional photoactive crosslinking compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| US-20100137469-A1 | AZIRIDINE-FUNCTIONAL PHOTOACTIVE CROSSLINKING COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137469-A1 | AZIRIDINE-FUNCTIONAL PHOTOACTIVE CROSSLINKING COMPOUNDS | PTMA, PAM, AAAS | MEN1 557/4885KMT2A 746/4885L3MBTL1 3963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.